Celebrating his 71st birthday this year, Czech chemist Professor Antonin Holy will also be able to celebrate the launch of clinical testing of a drug to treat non-Hodgkins Lymphoma (NHL) and chronic lymphatic leukaemia (CLL) - adding another to his 60+ registered patents.
Today little is known about the metabolism of the tuberculosis bacillus and, because of its slow growth, experiments for new drugs take a long time. Now a team of researchers form the University of Surrey built an in silico model of the agent that causes TB - a virtual TB bacillus - that promises to speed up the drug discovery process.
Congress President Professor Juergen Dunst MD praises major advances and multidisciplinary efforts, and outlines future hopes for breast cancer patients
The European Parliament voted for an EU Regulation on advanced therapies like gene therapy, cell therapy and tissue engineering. The decision, if adopted by the council, could open the door for innovative therapies which have a huge potential for curing diseases such as Parkionson´s, Alzheimer or cancer.
When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the previous discussions about a successor of Klaus Kleinfeld, but hardly anybody knew Loescher´s name in any enconomic context.
'Ultrasound-guided interventional pain therapy originates in ultrasound guided regional anaesthesia,' Dr Eichenberger explained.
Researchers have made a breakthrough by detecting the electrical equivalent of a living cell's last gasp. The work takes them a step closer to both seeing the 'heartbeat' of a living cell and a new way to test drugs.
The beautiful weather not only causes high spirit but also seasonal allergies. And as every year, over-the-counter allergy medications are booming, whereas most of the patients are extremely thoughtless concerning the use of antihistamines, not being aware of the side effects.
Due to a revised EU law, manufactures of medical devices are forced to label certain chemical ingredients in their products. This decision will enable hospitals to protect their patients against harm caused by toxic devices - if they are interested in. Because alternative products of course are connected with higher costs.
Many French pharmacists are falling on hard times after a year of falling revenues. Those most affected are in rural or semi-rural areas, where there is a growing shortage of doctors willing to set up practice or where resident GPs are leaving for the more populous towns.
Endovascular brachytherapy has been successfully modified by scientists at Isotopen Technologie München AG (ITM), solving problems of radiation exposure to Rhenium-188. The researchers are now producing Rhenium-188 with previously unknown high specific activity in a new type of generator, Isotopen Technologie reports.
The Martini Clinic, a private clinic located at the Hamburg-Eppendorf University Hospital (UKE), specialises exclusively in the diagnosis and therapy of one medical condition: prostate cancer.
In 2006, the German Medical Devices Industry grew by 8,7 % to 16 Euro billion. Major force behind this growth was export, which grew by 12,8 %, while the main export countries were EU member states, followed by North America. Domestic growth was disappointing.
Greece, Luxembourg, the Netherlands, Scotland, Spain and Switzerland are the first European countries affected by an increase of the influenza virus. Other countries will follow over the coming weeks and should prepare.
Fortunately, the influenza virus has not swapped over to Germany yet because the country has enough to do with the norovirus which is expected to attack up to one million people during the next weeks. People affected by the virus suffer from strong nausea and diarrhoea that last at least two days.
Siemens Medical Solutions strengthens its diagnostics devision, J&J wins stent patent appeal over Boston Scientific and Medtronic, Leica extends its product range and GE Healthcare cooperates with Ludwig-Maximilian-Universität in Munich as a reference center and strategic partner in developing cell-based assay modes.
A donation of the antibiotic Cipro® (Bayer HealthCare) with a wholesale value of more than US$ 25 million has been given to the non-profit organization MAP (Medical Assistance Programs) who will distribute it to clinics and hospitals in Africa and Latin America, which suffer badly from the lack of essential drugs.
Patients with swallowing difficulties could benefit from the new version of the exakt S Tablet Splitter.
Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this years German Congress of Senology.
Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.
Less bleeding complications due to safe citrate anticoagulation.
Affordable, effective and innovative products drive sales.
A new biodegradable solution has stopped bleeding in animals' wounds within seconds, according to a report in the journal Nanomedicine.
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
